Are you heading to G2 Lab Institute this fall? This year, it’s more important than ever for labs to understand how constant policy changes are influencing industry trends and patient care strategies. While you’re at the conference, don’t miss out on this featured speaking session:
Session Title: Case Study: How One Lab’s Growth Strategies Exceeded Sales Goals by 107% while Retaining 95% of Existing Business
Speaker: Nate Koenig, Chief Marketing Officer at Incyte Diagnostics, and Ryan Berk, Business Analyst, Incyte Diagnostics
Abstract: Despite declining reimbursements, pap utilization and the negative impact from hospital acquisitions, Incyte Diagnostics implemented a strategic growth plan that has produced an average of 16.7% net revenue growth per year over the past 5 years. During this time Incyte has been awarded 17 additional hospital contracts and grown by over 700 accounts. The team at Incyte prides themselves on a retention rate of 98.6% for clients located throughout Washington, Idaho, Montana, Alaska, and Oregon.
Date & Time: Thursday, October 26 @ 3:15 p.m.
Fill out the form on the right and schedule a 1:1 meeting during the conference to learn how hc1 can help your lab survive and thrive in the changing healthcare environment.